Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
Petrelli A, Rizzolio S, Pietrantonio F, Bellomo SE, Benelli M, De Cecco L, Romagnoli D, Berrino E, Orrù C, Ribisi S, Moya-Rull D, Migliore C, Conticelli D, Maina IM, Puliga E, Serra V, Pellegrino B, Llop-Guevara A, Musolino A, Siena S, Sartore-Bianchi A, Prisciandaro M, Morano F, Antista M, Fumagalli U, De Manzoni G, Degiuli M, Baiocchi GL, Amisano MF, Ferrero A, Marchiò C, Corso S, Giordano S. Petrelli A, et al. Cancer Res. 2023 May 15;83(10):1699-1710. doi: 10.1158/0008-5472.CAN-22-2620. Cancer Res. 2023. PMID: 37129948 Free PMC article.
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas.
Corso S, Pietrantonio F, Apicella M, Migliore C, Conticelli D, Petrelli A, D'Errico L, Durando S, Moya-Rull D, Bellomo SE, Ughetto S, Degiuli M, Reddavid R, Fumagalli U, De Pascale S, Sgroi G, Rausa E, Baiocchi GL, Molfino S, De Manzoni G, Bencivenga M, Siena S, Sartore-Bianchi A, Morano F, Corallo S, Prisciandaro M, Di Bartolomeo M, Gloghini A, Marsoni S, Sottile A, Sapino A, Marchiò C, Dahle-Smith A, Miedzybrodzka Z, Lee J, Ali SM, Ross JS, Alexander BM, Miller VA, Petty R, Schrock AB, Giordano S. Corso S, et al. Among authors: petrelli a. Clin Cancer Res. 2021 Jun 1;27(11):3126-3140. doi: 10.1158/1078-0432.CCR-20-0121. Epub 2021 Feb 4. Clin Cancer Res. 2021. PMID: 33542076 Free article.
Personalized therapeutic strategies in HER2-driven gastric cancer.
Ughetto S, Migliore C, Pietrantonio F, Apicella M, Petrelli A, D'Errico L, Durando S, Moya-Rull D, Bellomo SE, Rizzolio S, Capelôa T, Ribisi S, Degiuli M, Reddavid R, Rapa I, Fumagalli U, De Pascale S, Ribero D, Baronchelli C, Sgroi G, Rausa E, Baiocchi GL, Molfino S, Manenti S, Bencivenga M, Sacco M, Castelli C, Siena S, Sartore-Bianchi A, Tosi F, Morano F, Raimondi A, Prisciandaro M, Gloghini A, Marsoni S, Sottile A, Sarotto I, Sapino A, Marchiò C, Cassoni P, Guarrera S, Corso S, Giordano S. Ughetto S, et al. Among authors: petrelli a. Gastric Cancer. 2021 Jul;24(4):897-912. doi: 10.1007/s10120-021-01165-w. Epub 2021 Mar 23. Gastric Cancer. 2021. PMID: 33755862 Free article.
MicroRNAs impair MET-mediated invasive growth.
Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, Comoglio PM, Giordano S. Migliore C, et al. Among authors: petrelli a. Cancer Res. 2008 Dec 15;68(24):10128-36. doi: 10.1158/0008-5472.CAN-08-2148. Cancer Res. 2008. PMID: 19074879
YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC.
Ghiso E, Migliore C, Ciciriello V, Morando E, Petrelli A, Corso S, De Luca E, Gatti G, Volante M, Giordano S. Ghiso E, et al. Among authors: petrelli a. Neoplasia. 2017 Dec;19(12):1012-1021. doi: 10.1016/j.neo.2017.10.003. Epub 2017 Nov 11. Neoplasia. 2017. PMID: 29136529 Free PMC article.
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
Petrelli A, Bellomo SE, Sarotto I, Kubatzki F, Sgandurra P, Maggiorotto F, Di Virgilio MR, Ponzone R, Geuna E, Galizia D, Nuzzo AM, Medico E, Miglio U, Berrino E, Venesio T, Ribisi S, Provero P, Sapino A, Giordano S, Montemurro F. Petrelli A, et al. ESMO Open. 2020 Oct;5(5):e000937. doi: 10.1136/esmoopen-2020-000937. ESMO Open. 2020. PMID: 33122354 Free PMC article.
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming.
Kowalik MA, Puliga E, Cabras L, Sulas P, Petrelli A, Perra A, Ledda-Columbano GM, Morandi A, Merlin S, Orrù C, Sanchez-Martin C, Fornari F, Gramantieri L, Parri M, Rasola A, Bellomo SE, Sebastian C, Follenzi A, Giordano S, Columbano A. Kowalik MA, et al. Among authors: petrelli a. J Hepatol. 2020 Jun;72(6):1159-1169. doi: 10.1016/j.jhep.2019.12.018. Epub 2020 Jan 15. J Hepatol. 2020. PMID: 31954205
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).
Petrelli A, Perra A, Cora D, Sulas P, Menegon S, Manca C, Migliore C, Kowalik MA, Ledda-Columbano GM, Giordano S, Columbano A. Petrelli A, et al. Hepatology. 2014 Jan;59(1):228-41. doi: 10.1002/hep.26616. Epub 2013 Nov 18. Hepatology. 2014. PMID: 23857252 Free article.
186 results